Partial Versus Complete Bacillus Calmette-Guérin Intravesical Therapy and Bladder Cancer Outcomes in High-risk Non–muscle-invasive Bladder Cancer: Is NIMBUS the Full Story?

Partial Versus Complete Bacillus Calmette-Guérin Intravesical Therapy and Bladder Cancer Outcomes in High-risk Non–muscle-invasive Bladder Cancer: Is NIMBUS the Full Story?

Background: It is important to understand the implications of reduced bacillus Calmette-Guérin (BCG) treatment intensity, given global shortages and early termination of the NIMBUS trial. Objective: To assess the association of partial versus complete BCG induction with outcomes. Design, setting, an...

Full description

Bibliographic Details
Main Authors: Michael E. Rezaee, A. Aziz Ould Ismail, Chiamaka L. Okorie, John D. Seigne, Kristine E. Lynch, Florian R. Schroeck
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:European Urology Open Science
Subjects:
Bladder cancer
Bacillus Calmette-Guérin
Immunotherapy
Transurethral resection
Outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168321000161

Internet

http://www.sciencedirect.com/science/article/pii/S2666168321000161

Similar Items